Tulathromycin

Tulathromycin

Clinical data
AHFS/Drugs.com	International Drug Names
ATCvet code	Template:Infobox drug/formatATCvet Template:Infobox drug/formatATCvet
Identifiers
IUPAC name (2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-13-[[2,6-dideoxy-3-C-methyl-3-Ο-methyl-4-C-[(propylamino)methyl]-α-L-ribo-hexopyrano-syl]oxy]-2-ethyl-3,4,10-trihydroxy-3,5,8,10,12,14-hexamethyl-11-[[3,4,6-trideoxy-3-(dimethylamino)-β-D-xylo-hexopyranosyl]-oxy]-1-oxa-6-azacyclopentadecan-15-one
CAS Number	217500-96-4
ChemSpider	24583287 Y
UNII	Q839I13422
KEGG	D06258 Y
E number	{{#property:P628}}
ECHA InfoCard	{{#property:P2566}}
Chemical and physical data
Formula	C41H79N3O12
Molar mass	806.08 g/mol
3D model (JSmol)	Interactive image
SMILES CCCNCC1(C(OC(CC1(C)OC)OC2C(C(C(CC(NC(C(C(C(OC(=O)C2C)CC)(C)O)O)C)C)(C)O)OC3C(C(CC(O3)C)N(C)C)O)C)C)O
InChI InChI=1S/C40H77N3O12/c1-15-17-41-21-40(49)27(8)52-30(20-38(40,10)50-14)54-32-24(5)34(55-36-31(44)28(43(12)13)18-23(4)51-36)37(9,47)19-22(3)42-26(7)33(45)39(11,48)29(16-2)53-35(46)25(32)6/h22-34,36,41-42,44-45,47-49H,15-21H2,1-14H3/t22-,23-,24+,25-,26-,27+,28+,29-,30+,31-,32+,33-,34-,36+,37-,38-,39-,40+/m1/s1 Y Key:HWATWVYEWMIMSO-FROLMUNOSA-N Y
(verify)

WikiDoc Resources for Tulathromycin
Articles
Most recent articles on Tulathromycin Most cited articles on Tulathromycin Review articles on Tulathromycin Articles on Tulathromycin in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Tulathromycin Images of Tulathromycin Photos of Tulathromycin Podcasts & MP3s on Tulathromycin Videos on Tulathromycin
Evidence Based Medicine
Cochrane Collaboration on Tulathromycin Bandolier on Tulathromycin TRIP on Tulathromycin
Clinical Trials
Ongoing Trials on Tulathromycin at Clinical Trials.gov Trial results on Tulathromycin Clinical Trials on Tulathromycin at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Tulathromycin NICE Guidance on Tulathromycin NHS PRODIGY Guidance FDA on Tulathromycin CDC on Tulathromycin
Books
Books on Tulathromycin
News
Tulathromycin in the news Be alerted to news on Tulathromycin News trends on Tulathromycin
Commentary
Blogs on Tulathromycin
Definitions
Definitions of Tulathromycin
Patient Resources / Community
Patient resources on Tulathromycin Discussion groups on Tulathromycin Patient Handouts on Tulathromycin Directions to Hospitals Treating Tulathromycin Risk calculators and risk factors for Tulathromycin
Healthcare Provider Resources
Symptoms of Tulathromycin Causes & Risk Factors for Tulathromycin Diagnostic studies for Tulathromycin Treatment of Tulathromycin
Continuing Medical Education (CME)
CME Programs on Tulathromycin
International
Tulathromycin en Espanol Tulathromycin en Francais
Business
Tulathromycin in the Marketplace Patents on Tulathromycin
Experimental / Informatics
List of terms related to Tulathromycin

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Tulathromycin is a macrolide antibiotic used to treat bovine respiratory disease (BRD) in cattle and swine respiratory disease in pigs. It is marketed by Pfizer Inc. under the tradename Draxxin.

It is supplied as a solution for injection containing 100 mg of the drug.

External links

• Pfizer monograph for Draxxin (tulathromycin)